tiprankstipranks
Trending News
More News >
SANVO Fine Chemicals Group Limited (HK:0301)
:0301
Hong Kong Market

SANVO Fine Chemicals Group Limited (0301) AI Stock Analysis

Compare
0 Followers

Top Page

HK:0301

SANVO Fine Chemicals Group Limited

(0301)

Select Model
Select Model
Select Model
Neutral 56 (OpenAI - 5.2)
Rating:56Neutral
Price Target:
HK$1.50
▲(11.94% Upside)
Action:ReiteratedDate:11/12/25
The overall stock score of 56 reflects significant financial challenges, particularly in profitability and leverage, despite some positive cash flow trends. Technical analysis indicates strong bullish momentum, but the overbought RSI suggests caution. Valuation metrics are weak due to negative earnings and lack of dividends.
Positive Factors
Diversified revenue model & long-term contracts
SANVO’s revenue mix—custom synthesis, specialty intermediates and long-term contracts with pharma and agriculture—creates recurring demand and customer stickiness. Strategic partnerships expand distribution and capability, reducing reliance on spot sales and improving revenue predictability over months.
Improving cash generation
A resurgence in operating cash flow and a positive free cash flow position give SANVO durable operational flexibility. Positive FCF supports working capital, targeted capex, or debt paydown, improving resilience vs. pure earnings volatility and enabling strategic investments over the medium term.
Stable gross margin
A consistent gross margin near 29–30% indicates structural product-level pricing power or cost control in manufacturing. That stability protects core profitability against raw material swings and supports margin recovery if operating expenses are later optimized, underpinning longer-term margin sustainability.
Negative Factors
Negative net income & falling EBIT margins
Sustained negative net income and contracting EBIT margins reduce retained earnings and limit reinvestment capacity. Persistent operating losses can erode equity, constrain R&D or commercial expansion, and require ongoing cash or financing to support operations unless margins materially recover.
High leverage
A D/E of 1.25 indicates meaningful leverage that raises fixed servicing costs and reduces financial flexibility. High debt makes the company more sensitive to earnings shocks, limits strategic options, and increases refinancing risk if cash flows weaken, constraining durable growth initiatives.
Recent top-line deterioration
A year-over-year revenue decline highlights demand or execution issues that can persist without structural remedies. Top-line weakness limits operating leverage benefits and makes margin recovery harder; reversing this trend requires sustained commercial gains or new product uptake over multiple quarters.

SANVO Fine Chemicals Group Limited (0301) vs. iShares MSCI Hong Kong ETF (EWH)

SANVO Fine Chemicals Group Limited Business Overview & Revenue Model

Company DescriptionSANVO Fine Chemicals Group Limited, an investment holding company, researches and develops, manufactures, and sells fine industrial chemical products in the People's Republic of China, Australia, and internationally. The company operates through three segments: Aerosols, Organic Silicone Adhesives, and Synthetic Adhesive. The Aerosols segment offers spray paints and automotive care products, including spray paints, carburetor cleaners, spray waxes, anti-rust spray lubricants, polyurethane foams, cleaning sprays, and spray refrigerants for automobile air-conditioners. The Organic Silicone Adhesives segment provides silicone-based adhesive. The Synthetic Adhesive segment engages in the sale of multi-purpose contact adhesives. The company's products are used for hardware and building materials, and automotive maintenance applications. It sells its products under the SANVO and FullTeam brand names. SANVO Fine Chemicals Group Limited was founded in 1993 and is headquartered in Zhongshan, the People's Republic of China. SANVO Fine Chemicals Group Limited is a subsidiary of Sanvo Fine Chemicals Limited.
How the Company Makes MoneySANVO Fine Chemicals Group Limited generates revenue through multiple channels, primarily by offering tailored chemical solutions to its customers in various industries. The company’s revenue model is based on the sale of fine chemicals, which includes both standard products and custom synthesis services. Key revenue streams are derived from long-term contracts with pharmaceutical and agricultural companies that require specialized chemical formulations. Additionally, SANVO benefits from strategic partnerships with industry leaders, which enhance its market reach and product development capabilities. The company's ability to innovate and adapt its offerings based on market demands also plays a crucial role in sustaining its earnings.

SANVO Fine Chemicals Group Limited Financial Statement Overview

Summary
SANVO Fine Chemicals Group Limited shows mixed financial health. The company faces profitability challenges with negative net income and declining EBIT margins. Despite improvements in cash flow, significant leverage and a reduced equity position highlight financial risks.
Income Statement
45
Neutral
The company experienced a decline in revenue from 2023 to 2024. Gross profit margin is stable around 29-30%, but the net profit margin turned negative due to substantial losses, indicating profitability challenges. EBIT and EBITDA margins have also decreased significantly, highlighting issues with operational efficiency.
Balance Sheet
55
Neutral
The balance sheet shows an increase in total assets, but the debt-to-equity ratio is high at 1.25, signaling significant leverage. The equity ratio remains modest, suggesting moderate financial stability. Return on equity has deteriorated due to negative net income, posing potential risks.
Cash Flow
60
Neutral
Operating cash flow increased notably from 2023, and free cash flow turned positive. However, the free cash flow to net income ratio is low, reflecting operational struggles. The company shows signs of improving cash generation but faces profitability challenges.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.07B1.06B1.08B947.85M983.11M839.99M
Gross Profit329.48M314.44M311.94M260.99M261.92M268.94M
EBITDA4.11M7.03M34.97M20.71M28.77M81.85M
Net Income-32.13M-19.93M6.21M4.49M14.02M65.82M
Balance Sheet
Total Assets901.55M875.45M773.33M789.36M717.96M665.11M
Cash, Cash Equivalents and Short-Term Investments48.95M61.32M38.18M90.50M17.93M77.17M
Total Debt263.90M267.62M230.80M243.87M197.72M182.46M
Total Liabilities696.14M661.17M541.50M567.71M485.50M438.40M
Stockholders Equity205.41M214.28M231.79M221.65M232.46M226.71M
Cash Flow
Free Cash Flow5.64M19.37M4.84M18.71M-3.62M12.18M
Operating Cash Flow74.05M88.80M42.89M58.60M54.30M110.97M
Investing Cash Flow-64.69M-92.83M-60.86M-8.34M-83.36M-116.84M
Financing Cash Flow-32.28M22.89M-32.58M26.67M-32.72M68.21M

SANVO Fine Chemicals Group Limited Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1.34
Price Trends
50DMA
1.34
Positive
100DMA
1.36
Positive
200DMA
1.34
Positive
Market Momentum
MACD
0.03
Negative
RSI
58.21
Neutral
STOCH
66.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0301, the sentiment is Positive. The current price of 1.34 is below the 20-day moving average (MA) of 1.35, below the 50-day MA of 1.34, and below the 200-day MA of 1.34, indicating a bullish trend. The MACD of 0.03 indicates Negative momentum. The RSI at 58.21 is Neutral, neither overbought nor oversold. The STOCH value of 66.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:0301.

SANVO Fine Chemicals Group Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
HK$829.95M5.6220.67%8.71%25.95%44.12%
69
Neutral
HK$1.13B3.383.36%7.85%-5.37%25.20%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
56
Neutral
HK$682.17M-12.72-14.53%0.35%-153.95%
56
Neutral
HK$741.64M20.68-1.52%5.55%0.37%-331.54%
50
Neutral
HK$255.00M-1.48-15.93%-25.21%12.04%
49
Neutral
HK$335.05M-2.79-8.05%-24.13%-27.54%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:0301
SANVO Fine Chemicals Group Limited
1.45
0.49
51.04%
HK:0408
Yip's Chemical Holdings
2.00
0.67
50.15%
HK:0701
CNT Group Limited
0.18
-0.06
-26.05%
HK:1932
CPM Group Ltd.
0.26
0.03
11.84%
HK:1986
Tsaker New Energy Tech Co., Limited
0.77
0.09
13.24%
HK:0640
Infinity Development Holdings Co. Ltd.
2.62
0.88
50.57%

SANVO Fine Chemicals Group Limited Corporate Events

SANVO Fine Chemicals Announces Share Awards to Employees
Nov 10, 2025

SANVO Fine Chemicals Group Limited has announced the grant of 8,835,300 award shares to 157 employees under its 2023 Share Award Scheme. This initiative aims to incentivize employees, with shares vesting by November 2026, provided continuous employment is maintained. The grant does not include performance targets but has a clawback mechanism for specific misconduct, potentially impacting employee retention and motivation strategies.

The most recent analyst rating on (HK:0301) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on SANVO Fine Chemicals Group Limited stock, see the HK:0301 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 12, 2025